Avenue Therapeutics annual current ratio
2020
2021
2022
2023
2024
2025
Avenue Therapeutics Current Ratio Growth & History (ATXI)
Avenue Therapeutics's current ratio was 2.67 for fiscal 2025.
View full Avenue Therapeutics company overviewAvenue Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 2.67 | −0.61 | −18.55% |
| 2024 | 2024-12-31 | 3.27 | 1.73 | +111.69% |
| 2023 | 2023-12-31 | 1.55 | −0.37 | −19.12% |
| 2022 | 2022-12-31 | 1.91 | −5.87 | −75.42% |
| 2021 | 2021-12-31 | 7.78 | 4.12 | +112.42% |
| 2020 | 2020-12-31 | 3.66 | — | — |
Avenue Therapeutics quarterly current ratio
Q4.20
Q4.21
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.40 | −1.73 | −55.14% |
| Q1 2026 | 2026-03-31 | 1.94 | — | — |
| Q4 2025 | 2025-12-31 | 2.67 | — | — |
| Q3 2025 | 2025-09-30 | 2.62 | — | — |
| Q2 2025 | 2025-06-30 | 3.13 | — | — |
| Q4 2021 | 2021-12-31 | 7.78 | 4.12 | +112.42% |
| Q4 2020 | 2020-12-31 | 3.66 | — | — |
Avenue Therapeutics current ratio trends
Over the last five fiscal years, Avenue Therapeutics's current ratio decreased from 3.66 to 2.67, a change of −1.00. The latest reported quarter, Q2 2026, shows 1.40.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Avenue Therapeutics source filings ↗